Clinical trial

Sitagliptin/Metformin Fed Bioequivalence Study (0431A-080)

NCT00929201

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-01-01

PhasePHASE1

Study timeline

Study start (unknown)2008-01-01Date precision: month

Registry last updated2015-08-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Interventions

Sitagliptin phosphate/metformin hydrochloride FDCDRUG

Sitagliptin phosphateDRUG · verified · RxNorm: sitagliptin phosphate

Metformin hydrochlorideDRUG · verified · RxNorm: metformin hydrochloride

Sponsors & collaborators

Merck Sharp & Dohme LLClead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00929201 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.